Furthermore, the down-modulation of Tgase2 enhance the therapeutic efficacy of anti-cancer treatment in distinct mouse tumor models (200, 201), thus supporting the hypothesis of a crucial involvement of such protein in tumor progression and immune escape. The gene discussed is TGM2; the disease is cancer.